|
Nancy J. Wysenski was appointed Chief Operating Officer on September 6 2007. Ms. Wysenski a 30-year veteran of the health care industry most recently was the President of EMD Pharmaceuticals Inc. the U.S. subsidiary of Germany-based Merck KGaA. Prior to joining and co-founding EMD Ms. Wysenski was the Senior Vice President of Operations at NetGenics a venture capital-backed start-up company specializing in technologies for drug discovery. Earlier Ms. Wysenski held a number of positions of increasing scope and responsibility at Astra Merck culminating as Vice President of Sales. During her tenure at Astra Merck she also served on the company�s operating board. Prior to joining Astra Merck in 1990 she began her pharmaceutical industry career in 1984 at Merck Human Health where she held various positions of increasing responsibility. | 